Aug 10 (Reuters) – Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and research in the country. Pharmaceutical companies including
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
BRIEF-Kotyark Industries Says Receives Tender of 1.73 Billion Rupees For Supply Of Biodiesel
Aug 10 (Reuters) - Kotyark Industries Ltd: * KOTYARK INDUSTRIES - RECEIVES CONTRACT FOR SUPPLY…
Analysis-Crypto bill faces long odds after Senate punts vote to September
By Hannah Lang Aug 10 (Reuters) - The chances that the U.S. crypto industry will…
Oil prices jump, Wall Street and European shares under pressure with Hormuz, inflation in focus
By Chris Prentice and Harry Robertson NEW YORK/LONDON, Aug 10 (Reuters) - European shares and…
